These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18928026)

  • 1. Impact of withdrawal of Ritalin LA in the Western Cape.
    Donker Fv; Riordan G; Wilmshurst J
    S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 3. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks.
    Schulz E; Fleischhaker C; Hennighausen K; Heiser P; Haessler F; Linder M; Stollhoff K; Warnke A; Baier M; Klatt J
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):133-8. PubMed ID: 21432599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unlikely vice: Ritalin.
    Vishio J
    Adv Nurse Pract; 2001 Feb; 9(2):60. PubMed ID: 12416056
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic Ritalin use and cancer.
    Goldstein S
    J Atten Disord; 2010 Mar; 13(5):441. PubMed ID: 20190147
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 10. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.
    Goetz M; Surman CB; Mlynarova E; Krsek P
    J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167
    [No Abstract]   [Full Text] [Related]  

  • 12. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 13. Quillivant XR--an extended release oral suspension of methylphenidate.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
    [No Abstract]   [Full Text] [Related]  

  • 14. Question 2 Should a child with ADHD and epilepsy be given ritalin?
    Boyes C
    Arch Dis Child; 2010 Sep; 95(9):759-61. PubMed ID: 20716679
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder.
    Mutlu C; Bahalı K; Gunes H; Adaletli H
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):860-861. PubMed ID: 26397126
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on investigation of Ritalin conspiracy.
    J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):10. PubMed ID: 11197990
    [No Abstract]   [Full Text] [Related]  

  • 18. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H; Lewis J
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptensio XR--another long-acting methylphenidate.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.